Tag: interim analysis
Moderna Inc. Could Have Vaccine by December 2020
Keep an eye on Moderna Inc. (MRNA).
The COVID-19 vaccine stock is regaining some lost ground. All after CEO Stephane Bancel said the U.S. government...
Subscribe to our mailing list and get interesting stuff and updates to your email inbox.
*by submitting your information you agree to the terms of our Privacy Policy. You will receive FWeekly Stock Watch email and third party offers. You can unsubscribe anytime by selecting unsubscribe at the bottom of our emails.